Prague, Czechia

Marta Dvorakova

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Smart Brain S.r.o., Ustav Molekularni Genetiky Av Cr, V.v.i.. Active years: 2022.


% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marta Dvorakova: Innovator in Medicinal Chemistry

Introduction

Marta Dvorakova is a prominent inventor based in Prague, Czech Republic. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic agents. Her work focuses on the creation of phospholipid derivatives that hold promise for cancer treatment.

Latest Patents

Marta Dvorakova holds a patent for "Phospholipid derivatives and their use as medicaments." This invention relates to 1-acyl-lysophosphatidyl derivatives of a specific general formula. The derivatives are designed for the treatment of various types of cancer, including melanoma, hepatocarcinoma, and gastrointestinal tract carcinomas. The innovative nature of her work lies in the potential application of these compounds in cancer therapy.

Career Highlights

Throughout her career, Marta has worked with notable institutions such as the Institute of Molecular Genetics of the Czech Academy of Sciences and Smart Brain s.r.o. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Marta has collaborated with several professionals in her field, including Michal Dvorak and Vit Karafiat. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Marta Dvorakova is a trailblazer in the field of medicinal chemistry, with her innovative phospholipid derivatives paving the way for new cancer treatments. Her contributions to science and collaboration with other experts highlight her commitment to advancing medical research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…